SlideShare a Scribd company logo
1 of 1
Download to read offline
Regulatory subunit implicated in regulation of muscle protein degradation
Jesus Bracho
Advisor: Dr. Lewis Jacobson
Department of Biological Sciences, University of Pittsburgh
Acknowledgements
Conclusions
Future Questions
References
Opposing signaling pathways regulate degradation
The role and function of muscle protein degradation
1. Mutation in daf-2 induces rapid and thorough muscle degradation.
2. RNAi knockdown of PP2A subunit SUR-6 has no effect in PD55 strain, but
in daf-2 mutant prevents degradation from being as severe.
• Do the levels of phosphorylation on MEK change as predicted with the loss
of raf?
• Does the protein complex act on AKT or Raf?
• Can the complex be induced to other targets by changing the regulatory
subunit?
Funding for this project was
supported by the University of
Pittsburgh HHMI Undergraduate
Research Fellowship. Thank you to
Caitlin Miller for all the help. Thank
you to Jordan Sanders for the moral
support.
The degradation of muscle proteins is the consequence of a biological fail safe,
meant to provide an animal with amino acids to maintain vital protein synthesis in
the event of external stresses, such as starvation. It’s triggered in diseases such as
cancer and AIDS, as well as being the inevitable result of aging or disuse. This
process is regulated by a network of interacting protein kinases and phosphatases.
The study of this process holds implications for future drug treatments and
therapies.
Model organism C. elegans
This model organism has seen much favor in
the scientific community due to several
characteristics. Chiefly, its thoroughly
explored genome and developmental cycle, as
well as its genetic manipulability and rapid
life cycle. C. elegans is advantageous for
drawing conjecture about higher eukaryotes,
due to its many conserved gene functions.
The two pathways of interest are the MAPK and DAF-2/IGFR pathways. The
MAPK pathway promotes protein degradation, and the IGFR pathway inhibits it.
The MAPK pathway is halted at protein RAF through an inhibitory phosphate
added by AKT kinase, a downstream element of the IGFR pathway. We
hypothesize that a heterotrimeric protein complex PP2A stimulates protein
degradation by removing the inhibitory phosphate placed on RAF. The specificity
with which PP2A targets its substrates is based on which distinct regulatory
subunit it interacts with. PP2A, with regulatory subunit SUR6, is able to target and
activate RAF through the removal of the inhibitory phosphate placed by AKT, and
thus positively regulate muscle protein degradation.
Temperature sensitive DAF-2 mutant induces rapid muscle
protein degradation
RNAi knockdown of subunit SUR-6 opposes muscle protein
degradation
Figure 1c.
PD55 at 25°C
In order to control for other elements participating in these signaling pathways, I
first had to ensure a way to reliably induce muscle protein degradation. This was
accomplished through a mutant strain which possessed a temperature sensitive
defect in the DAF-2 insulin-like growth factor receptor (IGFR). At 25°C, DAF-2
can no longer interact with insulin, and the subsequent IGFR signaling pathway is
inactivated. This induces degradation due to the lack of AKT kinase to inactivate
Raf through phosphorylation. The histochemical stains above were taken from my
first experiment, carried out to ensure that the mutant performed ‘as advertised’.
The blue is indicative of the level of protein present in the organisms’ muscle cell
walls. Both strain and temperature were controlled for.
RNAi knockdown of subunit SUR-6 opposes muscle protein
degradation
Figure 2a.
PD55 + Null at 25°C
Figure 2b.
PD55 + Null at 25°C
Figure 2c.
PD55 + SUR6 at 25°C
Figure 2d.
PD55 + SUR6 at 25°C
Figure 2e.
PJ1741 + Null at 25°C
Figure 2f.
PJ1741 + Null at 25°C
Figure 2g.
PJ1741 + SUR6 at 25°C
Figure 2h.
PJ1741 + SUR6 at 25°C
Inhibiting gene expression of SUR6 would allow me to verify that it plays an
important role with PP2A in facilitating protein degradation. To do so, RNA
interference was utilized. Double stranded RNA specific to SUR6 was fed to
worms of both the control and mutant strains through bacteria at 16°C until the F1
generation was born. All strains were then moved to 25°C, where they sat for 48
hours. Histochemical stains were taken to compare mutant and RNAi
combinations against one another. RNAi was controlled for by feeding null
bacteria to both control and DAF-2 mutant worms.
DAF-2
Insulin
AKT Raf
FGFR
Autophagic
Degradation
Inhibitory
Phosphates
P
SUR-6
LET-92
PP2A
DAF-2
Insulin
AKT Raf
FGFR
Autophagic
Degradation
Inhibitory
Phosphates
P
SUR-6
LET-92
PP2A
DAF-2
Insulin
AKT Raf
FGFR
Autophagic
Degradation
Inhibitory
Phosphates
P
SUR-6
LET-92
PP2A
DAF-2
Insulin
AKT Raf
FGFR
Autophagic
Degradation
Inhibitory
Phosphates
P
SUR-6
LET-92
PP2A
PD55 + Null PD55 + SUR6 RNAi
PJ1741 + SUR6 RNAiPJ1741 + Null
Figure 1b.
PJ1741 at 16°C
Figure 1a.
PD55 at 16°C
Figure 1d.
PJ1741 at 25°C
1. Szewczyk N., Peterson B., Barmada S., Parkinson L.,
Jacobson L. “Opposed growth factor signals control protein
degradation in muscle of Caenorhabditis elegans.” The
EMBO Journal 26 (2007): 935-943. Print.
2. Padmanabhan, Srivatsan, Arnab Mukhopadhyay, Sri Devi
Narasimhan, Gregory Tesz, Michael P. Czech, and Heidi A.
Tissenbaum. "A PP2A Regulatory Subunit Regulates C.
Elegans Insulin/IGF-1 Signaling by Modulating AKT-1
Phosphorylation." Cell 136.5 (2009): 939-51. Print.
3. www.wormbase.org

More Related Content

What's hot

Reprint Microbiology-UK Aug 2014
Reprint Microbiology-UK Aug 2014Reprint Microbiology-UK Aug 2014
Reprint Microbiology-UK Aug 2014Shreya Dasgupta
 
Brian Covello: Diabetes Research Presentation Semester 2
Brian Covello: Diabetes Research Presentation Semester 2Brian Covello: Diabetes Research Presentation Semester 2
Brian Covello: Diabetes Research Presentation Semester 2Brian Covello
 
NAGLU_IGF2 in vitro studies
NAGLU_IGF2 in vitro studiesNAGLU_IGF2 in vitro studies
NAGLU_IGF2 in vitro studiesShih-hsin Kan
 
October 09 talk
October 09 talkOctober 09 talk
October 09 talkSky Lar
 
REU Final PowerPoint
REU Final PowerPointREU Final PowerPoint
REU Final PowerPointAlyssa Castle
 
Cobb ross cell signaling chapter
Cobb ross cell signaling chapterCobb ross cell signaling chapter
Cobb ross cell signaling chapterNusrat Gulbarga
 
PPAR alpha final research paper
PPAR alpha final research paperPPAR alpha final research paper
PPAR alpha final research paperEric Cobb
 
Radiation Protection : Phospholipase A
Radiation Protection : Phospholipase ARadiation Protection : Phospholipase A
Radiation Protection : Phospholipase ADmitri Popov
 
Brenna O-GlcNAc Final Poster
Brenna O-GlcNAc Final Poster Brenna O-GlcNAc Final Poster
Brenna O-GlcNAc Final Poster Brenna Seawalt
 
PPAR alpha poster
PPAR alpha posterPPAR alpha poster
PPAR alpha posterEric Cobb
 
Modulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibitionModulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibitionDavid Andrews
 
PERTURBAÇÕES INTUITIVAS DE 1901 CONFISCO (Baseados em conclusões do - b b...
PERTURBAÇÕES INTUITIVAS  DE  1901   CONFISCO (Baseados em conclusões do - b b...PERTURBAÇÕES INTUITIVAS  DE  1901   CONFISCO (Baseados em conclusões do - b b...
PERTURBAÇÕES INTUITIVAS DE 1901 CONFISCO (Baseados em conclusões do - b b...1901 Atos das Policias Internacionais
 

What's hot (20)

Reprint Microbiology-UK Aug 2014
Reprint Microbiology-UK Aug 2014Reprint Microbiology-UK Aug 2014
Reprint Microbiology-UK Aug 2014
 
Brian Covello: Diabetes Research Presentation Semester 2
Brian Covello: Diabetes Research Presentation Semester 2Brian Covello: Diabetes Research Presentation Semester 2
Brian Covello: Diabetes Research Presentation Semester 2
 
PPARs
PPARsPPARs
PPARs
 
NAGLU_IGF2 in vitro studies
NAGLU_IGF2 in vitro studiesNAGLU_IGF2 in vitro studies
NAGLU_IGF2 in vitro studies
 
October 09 talk
October 09 talkOctober 09 talk
October 09 talk
 
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando FloridaCristina Clement L08 presentation YI APS 2015 Orlando Florida
Cristina Clement L08 presentation YI APS 2015 Orlando Florida
 
REU Final PowerPoint
REU Final PowerPointREU Final PowerPoint
REU Final PowerPoint
 
StAR
StARStAR
StAR
 
Cobb ross cell signaling chapter
Cobb ross cell signaling chapterCobb ross cell signaling chapter
Cobb ross cell signaling chapter
 
PPAR alpha final research paper
PPAR alpha final research paperPPAR alpha final research paper
PPAR alpha final research paper
 
Radiation Protection : Phospholipase A
Radiation Protection : Phospholipase ARadiation Protection : Phospholipase A
Radiation Protection : Phospholipase A
 
publication 4
publication 4publication 4
publication 4
 
Brenna O-GlcNAc Final Poster
Brenna O-GlcNAc Final Poster Brenna O-GlcNAc Final Poster
Brenna O-GlcNAc Final Poster
 
PPAR alpha poster
PPAR alpha posterPPAR alpha poster
PPAR alpha poster
 
Modulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibitionModulating PIP2 levels in Cells via PIP5K inhibition
Modulating PIP2 levels in Cells via PIP5K inhibition
 
PERTURBAÇÕES INTUITIVAS DE 1901 CONFISCO (Baseados em conclusões do - b b...
PERTURBAÇÕES INTUITIVAS  DE  1901   CONFISCO (Baseados em conclusões do - b b...PERTURBAÇÕES INTUITIVAS  DE  1901   CONFISCO (Baseados em conclusões do - b b...
PERTURBAÇÕES INTUITIVAS DE 1901 CONFISCO (Baseados em conclusões do - b b...
 
Final Abstract
Final Abstract Final Abstract
Final Abstract
 
Session 4.3 Backer
Session 4.3 BackerSession 4.3 Backer
Session 4.3 Backer
 
Session 4.3: Backer
Session 4.3: BackerSession 4.3: Backer
Session 4.3: Backer
 
Cd20 antibody
Cd20 antibodyCd20 antibody
Cd20 antibody
 

Similar to HHMI Poster Final

Na f activates map ks and induces apoptosis in odontoblast-like
Na f activates map ks and induces apoptosis in odontoblast-likeNa f activates map ks and induces apoptosis in odontoblast-like
Na f activates map ks and induces apoptosis in odontoblast-likeGanesh Murthi
 
Teloomerase Research Paper
Teloomerase Research PaperTeloomerase Research Paper
Teloomerase Research PaperDawn Robertson
 
Targetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion diseaseTargetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion diseaseShahan Ullah
 
Sulforaphane and the NRF2 pathway as a treatment for DMD
Sulforaphane and the NRF2 pathway as a treatment for DMDSulforaphane and the NRF2 pathway as a treatment for DMD
Sulforaphane and the NRF2 pathway as a treatment for DMDJordan Gladman
 
MAPK Pathway in Skeletal Muscle Diseases
MAPK Pathway in Skeletal Muscle DiseasesMAPK Pathway in Skeletal Muscle Diseases
MAPK Pathway in Skeletal Muscle DiseasesAnnex Publishers
 
6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentationvincentlangat14
 
Summer Research Poster
Summer Research PosterSummer Research Poster
Summer Research PosterAlan Kim
 
Targeting unfolded protein response in neurodegeneration
Targeting unfolded protein response in neurodegenerationTargeting unfolded protein response in neurodegeneration
Targeting unfolded protein response in neurodegenerationShahan Ullah
 
The Two Component Stressors
The Two Component StressorsThe Two Component Stressors
The Two Component StressorsPatricia Viljoen
 
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...dgotto
 
Tumor suppression and inflammation: controlling the senescence associated se...
Tumor suppression and inflammation:  controlling the senescence associated se...Tumor suppression and inflammation:  controlling the senescence associated se...
Tumor suppression and inflammation: controlling the senescence associated se...adamfreund
 
The B30. 2 domain of pyrin, the familial mediterranean fever protein, interac...
The B30. 2 domain of pyrin, the familial mediterranean fever protein, interac...The B30. 2 domain of pyrin, the familial mediterranean fever protein, interac...
The B30. 2 domain of pyrin, the familial mediterranean fever protein, interac...José Luis Moreno Garvayo
 
Barshop December 2011
Barshop December 2011Barshop December 2011
Barshop December 2011Sky Lar
 
The interaction of Nrf2 and Glyoxalase I in response to lipid loading in Hepa...
The interaction of Nrf2 and Glyoxalase I in response to lipid loading in Hepa...The interaction of Nrf2 and Glyoxalase I in response to lipid loading in Hepa...
The interaction of Nrf2 and Glyoxalase I in response to lipid loading in Hepa...Farya Mubarik
 

Similar to HHMI Poster Final (20)

Na f activates map ks and induces apoptosis in odontoblast-like
Na f activates map ks and induces apoptosis in odontoblast-likeNa f activates map ks and induces apoptosis in odontoblast-like
Na f activates map ks and induces apoptosis in odontoblast-like
 
Teloomerase Research Paper
Teloomerase Research PaperTeloomerase Research Paper
Teloomerase Research Paper
 
Targetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion diseaseTargetting unfolded protein response in neurodegenrative disorder prion disease
Targetting unfolded protein response in neurodegenrative disorder prion disease
 
Sulforaphane and the NRF2 pathway as a treatment for DMD
Sulforaphane and the NRF2 pathway as a treatment for DMDSulforaphane and the NRF2 pathway as a treatment for DMD
Sulforaphane and the NRF2 pathway as a treatment for DMD
 
Vaillencourt
VaillencourtVaillencourt
Vaillencourt
 
MAPK Pathway in Skeletal Muscle Diseases
MAPK Pathway in Skeletal Muscle DiseasesMAPK Pathway in Skeletal Muscle Diseases
MAPK Pathway in Skeletal Muscle Diseases
 
6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation6 RTK signaling MAPK Akt.pdfCell signaling presentation
6 RTK signaling MAPK Akt.pdfCell signaling presentation
 
Summer Research Poster
Summer Research PosterSummer Research Poster
Summer Research Poster
 
Tyrosine kinase ppt
Tyrosine kinase pptTyrosine kinase ppt
Tyrosine kinase ppt
 
Targeting unfolded protein response in neurodegeneration
Targeting unfolded protein response in neurodegenerationTargeting unfolded protein response in neurodegeneration
Targeting unfolded protein response in neurodegeneration
 
JBC
JBCJBC
JBC
 
The Two Component Stressors
The Two Component StressorsThe Two Component Stressors
The Two Component Stressors
 
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
Signaling events triggered by inactivation of the TSC1-2 Complex: Implication...
 
Hippo signal pathway
Hippo signal pathwayHippo signal pathway
Hippo signal pathway
 
Tumor suppression and inflammation: controlling the senescence associated se...
Tumor suppression and inflammation:  controlling the senescence associated se...Tumor suppression and inflammation:  controlling the senescence associated se...
Tumor suppression and inflammation: controlling the senescence associated se...
 
The B30. 2 domain of pyrin, the familial mediterranean fever protein, interac...
The B30. 2 domain of pyrin, the familial mediterranean fever protein, interac...The B30. 2 domain of pyrin, the familial mediterranean fever protein, interac...
The B30. 2 domain of pyrin, the familial mediterranean fever protein, interac...
 
PI3 kinase pathway
PI3 kinase pathwayPI3 kinase pathway
PI3 kinase pathway
 
FISV2008
FISV2008FISV2008
FISV2008
 
Barshop December 2011
Barshop December 2011Barshop December 2011
Barshop December 2011
 
The interaction of Nrf2 and Glyoxalase I in response to lipid loading in Hepa...
The interaction of Nrf2 and Glyoxalase I in response to lipid loading in Hepa...The interaction of Nrf2 and Glyoxalase I in response to lipid loading in Hepa...
The interaction of Nrf2 and Glyoxalase I in response to lipid loading in Hepa...
 

HHMI Poster Final

  • 1. Regulatory subunit implicated in regulation of muscle protein degradation Jesus Bracho Advisor: Dr. Lewis Jacobson Department of Biological Sciences, University of Pittsburgh Acknowledgements Conclusions Future Questions References Opposing signaling pathways regulate degradation The role and function of muscle protein degradation 1. Mutation in daf-2 induces rapid and thorough muscle degradation. 2. RNAi knockdown of PP2A subunit SUR-6 has no effect in PD55 strain, but in daf-2 mutant prevents degradation from being as severe. • Do the levels of phosphorylation on MEK change as predicted with the loss of raf? • Does the protein complex act on AKT or Raf? • Can the complex be induced to other targets by changing the regulatory subunit? Funding for this project was supported by the University of Pittsburgh HHMI Undergraduate Research Fellowship. Thank you to Caitlin Miller for all the help. Thank you to Jordan Sanders for the moral support. The degradation of muscle proteins is the consequence of a biological fail safe, meant to provide an animal with amino acids to maintain vital protein synthesis in the event of external stresses, such as starvation. It’s triggered in diseases such as cancer and AIDS, as well as being the inevitable result of aging or disuse. This process is regulated by a network of interacting protein kinases and phosphatases. The study of this process holds implications for future drug treatments and therapies. Model organism C. elegans This model organism has seen much favor in the scientific community due to several characteristics. Chiefly, its thoroughly explored genome and developmental cycle, as well as its genetic manipulability and rapid life cycle. C. elegans is advantageous for drawing conjecture about higher eukaryotes, due to its many conserved gene functions. The two pathways of interest are the MAPK and DAF-2/IGFR pathways. The MAPK pathway promotes protein degradation, and the IGFR pathway inhibits it. The MAPK pathway is halted at protein RAF through an inhibitory phosphate added by AKT kinase, a downstream element of the IGFR pathway. We hypothesize that a heterotrimeric protein complex PP2A stimulates protein degradation by removing the inhibitory phosphate placed on RAF. The specificity with which PP2A targets its substrates is based on which distinct regulatory subunit it interacts with. PP2A, with regulatory subunit SUR6, is able to target and activate RAF through the removal of the inhibitory phosphate placed by AKT, and thus positively regulate muscle protein degradation. Temperature sensitive DAF-2 mutant induces rapid muscle protein degradation RNAi knockdown of subunit SUR-6 opposes muscle protein degradation Figure 1c. PD55 at 25°C In order to control for other elements participating in these signaling pathways, I first had to ensure a way to reliably induce muscle protein degradation. This was accomplished through a mutant strain which possessed a temperature sensitive defect in the DAF-2 insulin-like growth factor receptor (IGFR). At 25°C, DAF-2 can no longer interact with insulin, and the subsequent IGFR signaling pathway is inactivated. This induces degradation due to the lack of AKT kinase to inactivate Raf through phosphorylation. The histochemical stains above were taken from my first experiment, carried out to ensure that the mutant performed ‘as advertised’. The blue is indicative of the level of protein present in the organisms’ muscle cell walls. Both strain and temperature were controlled for. RNAi knockdown of subunit SUR-6 opposes muscle protein degradation Figure 2a. PD55 + Null at 25°C Figure 2b. PD55 + Null at 25°C Figure 2c. PD55 + SUR6 at 25°C Figure 2d. PD55 + SUR6 at 25°C Figure 2e. PJ1741 + Null at 25°C Figure 2f. PJ1741 + Null at 25°C Figure 2g. PJ1741 + SUR6 at 25°C Figure 2h. PJ1741 + SUR6 at 25°C Inhibiting gene expression of SUR6 would allow me to verify that it plays an important role with PP2A in facilitating protein degradation. To do so, RNA interference was utilized. Double stranded RNA specific to SUR6 was fed to worms of both the control and mutant strains through bacteria at 16°C until the F1 generation was born. All strains were then moved to 25°C, where they sat for 48 hours. Histochemical stains were taken to compare mutant and RNAi combinations against one another. RNAi was controlled for by feeding null bacteria to both control and DAF-2 mutant worms. DAF-2 Insulin AKT Raf FGFR Autophagic Degradation Inhibitory Phosphates P SUR-6 LET-92 PP2A DAF-2 Insulin AKT Raf FGFR Autophagic Degradation Inhibitory Phosphates P SUR-6 LET-92 PP2A DAF-2 Insulin AKT Raf FGFR Autophagic Degradation Inhibitory Phosphates P SUR-6 LET-92 PP2A DAF-2 Insulin AKT Raf FGFR Autophagic Degradation Inhibitory Phosphates P SUR-6 LET-92 PP2A PD55 + Null PD55 + SUR6 RNAi PJ1741 + SUR6 RNAiPJ1741 + Null Figure 1b. PJ1741 at 16°C Figure 1a. PD55 at 16°C Figure 1d. PJ1741 at 25°C 1. Szewczyk N., Peterson B., Barmada S., Parkinson L., Jacobson L. “Opposed growth factor signals control protein degradation in muscle of Caenorhabditis elegans.” The EMBO Journal 26 (2007): 935-943. Print. 2. Padmanabhan, Srivatsan, Arnab Mukhopadhyay, Sri Devi Narasimhan, Gregory Tesz, Michael P. Czech, and Heidi A. Tissenbaum. "A PP2A Regulatory Subunit Regulates C. Elegans Insulin/IGF-1 Signaling by Modulating AKT-1 Phosphorylation." Cell 136.5 (2009): 939-51. Print. 3. www.wormbase.org